Skip to main content
The Egyptian Heart Journal

Table 8 Showing comparison between population without significant PVL and population with significant PVL

From: Impact of prosthesis oversizing on clinical outcomes of transcatheter aortic valve implantation using a self-expandable Evolut R valve

 

Non significant PVL

Significant PVL

Test value

P-value

Sig.

 

No. = 129

No. = 14

Age (years)

Female

54 (41.9%)

6 (42.9%)

0.005*

0.943

NS

 

Male

75 (58.1%)

8 (57.1%)

   

Weight (kg)

Mean ± SD

73.82 ± 6.23

73.64 ± 9.33

0.097•

0.923

NS

 

Range

59–87

55–88

   

Height (m)

Mean ± SD

79.00 ± 14.39

82.07 ± 14.33

 − 0.758•

0.450

NS

 

Range

50–125

50–99.5

   

BMI(kg/m2)

Mean ± SD

1.65 ± 0.07

1.64 ± 0.09

0.227•

0.820

NS

 

Range

1.5–1.82

1.5–1.82

   

BSA (m2)

Mean ± SD

29.07 ± 5.19

29.09 ± 5.22

 − 0.010•

0.992

NS

 

Range

18.82–47.87

22.22–41.42

   

Age (years)

Mean ± SD

1.87 ± 0.17

1.88 ± 0.21

 − 0.083•

0.934

NS

 

Range

1.52–2.39

1.44–2.1

   

Euro score II %

Median (IQR)

3.35 (1.95–5.2)

4.26 (2.56–10.1)

 − 1.654‡

0.098

NS

 

Range

0.84–40.2

1.24–14.54

   

STS score %

Median (IQR)

2.45 (1.7–3.52)

2.97 (1.89–3.78)

 − 0.988‡

0.323

NS

 

Range

0.66–16.98

1.27–10.2

   

CABG

No

117 (90.7%)

13 (92.9%)

0.071*

0.790

NS

 

Yes

12 (9.3%)

1 (7.1%)

   

Smoking

Non-smoker

97 (75.2%)

10 (71.4%)

0.992*

0.609

NS

 

Smoker

23 (17.8%)

2 (14.3%)

   
 

EX -smoker

9 (7.0%)

2 (14.3%)

   

DM

No

64 (49.6%)

11 (78.6%)

4.247*

0.039

S

 

Yes

65 (50.4%)

3 (21.4%)

   

HTN

No

29 (22.5%)

4 (28.6%)

0.264*

0.607

NS

 

Yes

100 (77.5%)

10 (71.4%)

   

IHD

No

78 (60.5%)

9 (64.3%)

0.077*

0.781

NS

 

Yes

51 (39.5%)

5 (35.7%)

   

CVS

No

121 (93.8%)

13 (92.9%)

0.019*

0.890

NS

 

Yes

8 (6.2%)

1 (7.1%)

   

CrCl (ml/m2)

Mean ± SD

63.70 ± 27.15

61.23 ± 23.30

0.327•

0.744

NS

 

Range

9–161

24.32–106

   

CLD

No

119 (92.2%)

13 (92.9%)

0.007*

0.935

NS

 

Yes

10 (7.8%)

1 (7.1%)

   

Severe or non severe aortic Calcification

Grade (1–3)

80 (62.0%)

4 (28.6%)

5.829*

0.016

S

 

Grade 4

49 (38.0%)

10 (71.4%)

   

Grades of aortic calcifications

Grade 1

1 (0.8%)

0 (0.0%)

6.742*

0.081

NS

 

Grade 2

24 (18.6%)

0 (0.0%)

   
 

Grade 3

55 (42.6%)

4 (28.6%)

   
 

Grade 4

49 (38.0%)

10 (71.4%)

   

Septal Calcification

No

111 (86.0%)

12 (85.7%)

0.001*

0.973

NS

 

Yes

18 (14.0%)

2 (14.3%)

   

Annulus diameter indexed (mm/m2)

Mean ± SD

24.14 ± 1.75

24.43 ± 1.53

 − 0.596•

0.552

NS

 

Range

20–28.4

22.6–27.8

   

Annulus perimeter (mm)

Mean ± SD

12.97 ± 1.32

13.18 ± 1.99

 − 0.557•

0.579

NS

 

Range

8.93–16.99

11.21–17.48

   

Annulus perimeter. Indexed (mm/m2)

Mean ± SD

77.88 ± 5.12

78.77 ± 4.85

 − 0.615•

0.539

NS

 

Range

69–92

73.2–90.1

   

Annulus Area (mm2)

Mean ± SD

41.83 ± 4.13

42.46 ± 6.02

 − 0.517•

0.606

NS

 

Range

34.17–53.78

36.7–56.6

   

Annulus Area indexed (mm2/m2)

Mean ± SD

459.61 ± 62.92

471.99 ± 62.72

 − 0.699•

0.486

NS

 

Range

339–666

392.6–601

   

Annulus Diameter.indexed (mm/m2)

Mean ± SD

246.62 ± 36.06

254.71 ± 49.07

 − 0.768•

0.444

NS

 

Range

166.91–355.3

203.1–377

   

DI (mm)

Median (IQR)

3.15 (2.4–4.6)

2.8 (2–5.2)

 − 0.347‡

0.729

NS

 

Range

1–8

1–8

   

DI I (mm/m2)

Median (IQR)

1.74 (1.27–2.41)

1.57 (1.19–2.64)

 − 0.071‡

0.943

NS

 

Range

0.42–4.6

0.51–4.24

   

DIMS %

Median (IQR)

37.5 (24.74–58)

29.25 (24.1–62.5)

 − 0.455‡

0.649

NS

 

Range

10–113.9

14.29–114.23

   

Pre implantation-dilatation

No

99 (76.7%)

8 (57.1%)

2.576*

0.108

NS

 

Yes

30 (23.3%)

6 (42.9%)

   

Post- implantation dilatation

No

117 (90.7%)

1 (7.1%)

61.119*

0.000

HS

 

Yes

12 (9.3%)

13 (92.9%)

   

RHD

No

122 (94.6%)

14 (100.0%)

0.799*

0.371

NS

 

Yes

7 (5.4%)

0 (0.0%)

   

DIDO%

Mean ± SD

16.94 ± 5.91

12.93 ± 4.98

2.445•

0.016

S

 

Range

1–30

0–19

   
  1. BMI Body mass index, BSA Body surface area, Ca Calcification, CABG Coronary artery bypass graft, CLD Chronic lung disease, CrCl Creatinine clearance, CVS Cerebrovascular stroke, DIDO Depth of implantation derived oversizing index, DI Depth of implantation, DI Depth of implantation indexed, DIMS Depth of implantation to membranous septum ratio, DM Diabetes mellitus, EF Ejection fraction, HTN Hypertension, IHD ischemic heart disease, MS Membranous septum, MSi Membranous septum indexed, RHD Rheumatic heart disease, STS PROM Society of thoracic surgery predicted risk of mortality
  2. P-value > 0.05: Non significant (NS); P-value < 0.05: Significant (S); P-value < 0.01: highly significant (HS)
  3. ‡Mann Whitney test
  4. *Chi-square test
  5. •Independent t-test
Back to article page